Clincosm LogoSign in Get a demo

Effects of Red Ginseng on Liver Function

Sponsor
Chuncheon Sacred Heart Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03945123
Collaborator
(none)
94
Enrollment
1
Location
1
Arm
12
Actual Duration (Months)
7.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Korea Red Ginseng (KRG) has effect on liver function

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Red ginseng
 N/A

Detailed Description

Korea Red Ginseng (KRG) has been known as a natural product with anti-inflammatory effect in liver disease. Gut microbiota plays an important roles in the pathophysiology of nonalcoholic statohepatitis (NASH). We evaluated the effect of KRG on the pathophysiology of NASH

Study Design

Study Type:
Interventional
Actual Enrollment :
94 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Korea Red Ginseng on Non-alcoholic Fatty Liver Disease
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ginseng trial

compare experimental group to controlled group

Dietary Supplement: Red ginseng
Red ginseng tablet 120g
Other Names:
  • Red ginseng tablet

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Liver enzyme [1year]

      Decrease liver enzyme level

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    37 Years to 63 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • AST or ALT level > 50 IU/L
    Exclusion Criteria:

    • Viral hepatitis

    • Alcoholic hepatitis

    • Autoimmune hepatitis

    • Pancreatitis

    • Hemochromatosis

    • Wilson's disease

    • Drug induced liver injury

    • Cancer

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ChuncheonSHH Chuncheon Kangwon Korea, Republic of

    Sponsors and Collaborators

    • Chuncheon Sacred Heart Hospital

    Investigators

    • Study Chair: Ki Tae Suk, PhD.Md., Chuncheon Sacred Heart Hospital
    • Principal Investigator: Jun Seok, MD., Chuncheon Sacred Heart Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ki Tae Suk, Proffesor, Chuncheon Sacred Heart Hospital
    ClinicalTrials.gov Identifier:
    NCT03945123
    Other Study ID Numbers:
    • RIVER
    First Posted:
    May 10, 2019
    Last Update Posted:
    May 10, 2019
    Last Verified:
    May 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ki Tae Suk, Proffesor, Chuncheon Sacred Heart Hospital
    ginseng
    Liver
    Additional relevant MeSH terms:
    Liver Diseases

    Study Results

    No Results Posted as of May 10, 2019